目前,在世界范围内中国是仅次于印度的结核病大国。结核病仍然是影响人民健康,制约社会经济发展的重大传染病之一,特别耐药问题,是现代结核病控制遇到的巨大挑战。据世界卫生组织报道,全世界约有三分之二的结核病人处于发生耐多药结核病的危险之中。一些疫情高负担国家耐药结核病呈增加趋势,我国耐药问题也相当严重。第 At present, China is the second largest tuberculosis country in India after the rest of the world. Tuberculosis remains one of the major infectious diseases that affect people’s health and restricts social and economic development. The problem of special drug resistance is a huge challenge to modern TB control. According to the World Health Organization, about two-thirds of all tuberculosis patients in the world are at risk of developing MDR-TB. Some high-burden epidemic-resistant countries have shown an upward trend in drug-resistant TB, and the problem of drug resistance in China is also quite serious. No.